The short version
- Czechia allowed medical psilocybin starting January 1, 2026, through specially trained psychiatrists.
- Australia has allowed authorized psychiatrists to prescribe psilocybin for treatment-resistant depression since 2023.
- Canada, Germany, Switzerland, New Zealand, and Denmark allow limited special or compassionate access.
- In the U.S., access runs through state programs and clinical trials.
Czechia's new law
Czechia amended its laws so that, starting January 1, 2026, doctors can prescribe an individually prepared medicine containing psilocybin.1 The system is tightly controlled:
- Only certified psychiatrists with specialized psychedelic therapy training can administer it, and there are only a few dozen in the country, mostly in Prague and Brno.
- It's aimed at treatment-resistant depression and other serious psychiatric conditions where standard treatments haven't worked, such as depression that accompanies a cancer diagnosis.
- Sessions involve two qualified therapists and typically last about six hours.
- The initial rollout is expected to reach only a few dozen patients a year, and health insurers have to agree to cover it.2
Czech officials have said it's hard to imagine the treatment being available only to people who can pay out of pocket, which puts insurance coverage at the center of the rollout.2
Where medical psilocybin is legal
| Country or region | Type of access |
|---|---|
| Australia | Authorized psychiatrists can prescribe for treatment-resistant depression (since 2023) |
| Czechia | Medical prescribing by certified psychiatrists (since January 2026)1 |
| Alberta, Canada | Provincial framework for psychedelic-assisted treatment1 |
| Canada (federal) | Case-by-case special access1 |
| Germany | Compassionate use program for treatment-resistant depression (2025)13 |
| Switzerland | Individual exemptions for authorized psychiatrists since 20141 |
| New Zealand | Special access with government approval; first approval in June 20251 |
| Denmark | Exceptional circumstances only1 |
| United States | State programs in Oregon and Colorado, New Mexico medical program in development, a Utah hospital pilot, and clinical trials1 |
Medical access is not the same as recreational legality. In most of these places, possessing mushrooms outside the medical system is still illegal. The Netherlands is a well-known exception for a different reason: psilocybin truffles, the underground form of some species, are sold legally, while mushrooms are banned.
The pattern
A 2026 review of medical psilocybin laws around the world found the same two models repeating. Some places build structured prescribing systems with trained specialists, like Australia and Czechia. Others offer narrow exceptions for individual patients, like Canada's federal special access or Germany's compassionate use program.4 The U.S. is unusual in having adult-use state programs that don't require a diagnosis at all.
What it means for Americans
If the FDA approves psilocybin for depression in 2027, the U.S. will likely end up with a medical model closer to Czechia's: trained clinicians, supervised sessions, and a fight over insurance coverage. Until then, see psilocybin laws by state and our therapist finder.
Sources
- Drug Science. Psilocybin regulation in 2026. drugscience.org.uk
- Expats.cz. Medical use of magic mushrooms to become legal in Czechia from 2026. expats.cz
- The Microdose. Germany approves compassionate use psilocybin. themicrodose.substack.com
- Preprints.org. Comparative medico-legal frameworks for psilocybin regulation: a March 2026 update. doi.org/10.20944/preprints202604.1423.v1
This article is for education only and is not medical or legal advice. Psilocybin is a Schedule I substance under U.S. federal law. Talk with a licensed clinician before making decisions about your health. In a crisis, call or text 988.